Elad Prinz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elad Prinz has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Mukherjee
Department of Genetics and Developmental Biology, Rappaport Faculty of Medicine, Technion—Israel Institute of Technology, Haifa, Israel 1
1 shared publication - Alon Kaplan
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel
1 shared publication - Ana Belkin
Department of Internal Medicine D, Sheba Medical Center, Ramat Gan, Israel
1 shared publication - Avshalom Leibowitz
Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan 5265601, Israel
1 shared publication - Batya Sarna
Department of Internal Medicine D, Sheba Medical Center, Ramat Gan, Israel
1 shared publication - Dana Lev
The Center for Geographic Medicine and Tropical Diseases, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel
1 shared publication
Latest Publications
- Open Access
- 11 November 2026
- Published by Springer Nature in BMC Geriatrics
Handgrip strength and 4-meter walk performance as practical functional measures of sarcopenia and physiologic reserve in acute hospital care: a prospective cohort study
Background: Functional reserve is difficult to characterize during routine acute hospital care. Sarcopenia is associated with frailty, disability, and mortality, but rapid functional assessment remains underused in hospitalized older adults. We evaluated handgrip strength and 4-meter walk test (4MWT) performance as pragmatic measures of probable sarcopenia and physiologic reserve during acute illness. Methods: We conducted a prospective cohort study of 279 hospitalized adults aged 65–95 years at a tertiary medical center. Handgrip strength was measured using dynamometry; values < 27 kg in men and < 16 kg in women were classified as probable sarcopenia according to EWGSOP2. Among 169 participants who completed the 4MWT without an assistive device, associations between probable sarcopenia, walk time, age, and sex were evaluated using linear regression. Selection into the 4MWT subgroup was examined using inverse-probability weighting (IPW). Results: Participants with probable sarcopenia were underrepresented in the 4MWT subgroup. In the 169 participants with eligible 4MWT measurements, probable sarcopenia was independently associated with a 1.59-second longer walk time after adjustment for age and sex (95% CI 0.55–2.63; P = 0.003). The IPW estimate was similar (β = 1.62 s, 95% CI 0.49–2.75; P = 0.005). In an exploratory overlapping age-window analysis, concordance was greatest in the 73–84-year interval (AUC = 0.69, bootstrap 95% CI 0.58–0.80). Conclusions: Handgrip strength is a rapid bedside-feasible measure, whereas the 4MWT is a complementary ward-based assessment for sufficiently mobile and clinically stable hospitalized older adults. These state-dependent measures characterize functional performance and physiologic reserve during acute illness; longitudinal studies are required to determine their relationship to baseline function, recovery, and healthspan outcomes.
- 11 November 2026
- Published by Springer Nature in BMC Geriatrics
Open AccessHandgrip strength and 4-meter walk performance as practical functional measures of sarcopenia and physiologic reserve in acute hospital care: a prospective cohort study
Background: Functional reserve is difficult to characterize during routine acute hospital care. Sarcopenia is associated with frailty, disability, and mortality, but rapid functional assessment remains underused in hospitalized older adults. We evaluated handgrip strength and 4-meter walk test (4MWT) performance as pragmatic measures of probable sarcopenia and physiologic reserve during acute illness. Methods: We conducted a prospective cohort study of 279 hospitalized adults aged 65–95 years at a tertiary medical center. Handgrip strength was measured using dynamometry; values < 27 kg in men and < 16 kg in women were classified as probable sarcopenia according to EWGSOP2. Among 169 participants who completed the 4MWT without an assistive device, associations between probable sarcopenia, walk time, age, and sex were evaluated using linear regression. Selection into the 4MWT subgroup was examined using inverse-probability weighting (IPW). Results: Participants with probable sarcopenia were underrepresented in the 4MWT subgroup. In the 169 participants with eligible 4MWT measurements, probable sarcopenia was independently associated with a 1.59-second longer walk time after adjustment for age and sex (95% CI 0.55–2.63; P = 0.003). The IPW estimate was similar (β = 1.62 s, 95% CI 0.49–2.75; P = 0.005). In an exploratory overlapping age-window analysis, concordance was greatest in the 73–84-year interval (AUC = 0.69, bootstrap 95% CI 0.58–0.80). Conclusions: Handgrip strength is a rapid bedside-feasible measure, whereas the 4MWT is a complementary ward-based assessment for sufficiently mobile and clinically stable hospitalized older adults. These state-dependent measures characterize functional performance and physiologic reserve during acute illness; longitudinal studies are required to determine their relationship to baseline function, recovery, and healthspan outcomes.
- Open Access
Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
Tumor cell heterogeneity is primarily dictated by mutational changes, sometimes leading to clones that undergo a metastatic switch. However, little is known about tumor heterogeneity following chemotherapy perturbation. Here we studied the possible involvement of tumor-derived extracellular vesicles, often referred to as tumor-derived microparticles (TMPs), as mediators of the metastatic switch in the tumor microenvironment by hindering cell adhesion properties. Specifically, we show that highly metastatic or chemotherapy-treated breast cancer cells shed an increased number of TMPs compared to their respective controls. We found that these TMPs substantially reduce cell adhesion and disrupt actin filament structure, therefore increasing their biomechanical force pace, further implicating tumor cell dissemination as part of the metastatic cascade. Our results demonstrate that these pro-metastatic effects are mediated in part by CD44 which is highly expressed in TMPs obtained from highly metastatic cells or cells exposed to chemotherapy when compared to cells with low metastatic potential. Consequently, when we inhibited CD44 expression on TMPs by a pharmacological or a genetic approach, increased tumor cell adhesion and re-organized actin filament structure were observed. We also demonstrated that breast cancer patients treated with paclitaxel chemotherapy exhibited increased CD44-expressing TMPs. Overall, our study provides further insights into the role of TMPs in promoting metastasis, an effect which is augmented when tumor cells are exposed to chemotherapy.
Open AccessBreast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
Tumor cell heterogeneity is primarily dictated by mutational changes, sometimes leading to clones that undergo a metastatic switch. However, little is known about tumor heterogeneity following chemotherapy perturbation. Here we studied the possible involvement of tumor-derived extracellular vesicles, often referred to as tumor-derived microparticles (TMPs), as mediators of the metastatic switch in the tumor microenvironment by hindering cell adhesion properties. Specifically, we show that highly metastatic or chemotherapy-treated breast cancer cells shed an increased number of TMPs compared to their respective controls. We found that these TMPs substantially reduce cell adhesion and disrupt actin filament structure, therefore increasing their biomechanical force pace, further implicating tumor cell dissemination as part of the metastatic cascade. Our results demonstrate that these pro-metastatic effects are mediated in part by CD44 which is highly expressed in TMPs obtained from highly metastatic cells or cells exposed to chemotherapy when compared to cells with low metastatic potential. Consequently, when we inhibited CD44 expression on TMPs by a pharmacological or a genetic approach, increased tumor cell adhesion and re-organized actin filament structure were observed. We also demonstrated that breast cancer patients treated with paclitaxel chemotherapy exhibited increased CD44-expressing TMPs. Overall, our study provides further insights into the role of TMPs in promoting metastasis, an effect which is augmented when tumor cells are exposed to chemotherapy.